The findings suggest that GLP-1 medications may act on a shared biological pathway underlying multiple forms of addiction
The FDA, too, has cautioned about the potential danger of the compounds, and leading obesity medicine groups starkly warn patients against their use
Winter Considerations for Canadian Timeline Canadian winters affect the Retatrutide timeline experience: Shipping during cold months: Peptides must maintain temperature control
The bold move has been accompanied by a full-page ad in the Wall Street Journal explaining its reasoning, and claiming that the prices of GLP-1 drugs for weight loss are five times too high and need to be brought in line with levels in other countries
Here are all the membership benefits, join now!Show notesThis week our headline topic is a "concussion sensor" being trialled by some teams at the Tour de France, and why it is a welcome innovation, but one that, for now, invites potentially dangerous false hope
Clinical efficacy depends on dose, patient adherence, and individual biologynot the manufacturing origin
